Global Fusion Proteins Market to Reach $38.4 Billion by 2030

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

 | Source: ReportLinker ReportLinker

New York, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Fusion Proteins Industry" - https://www.reportlinker.com/p06031657/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Fusion Proteins Market to Reach $38.4 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Fusion Proteins estimated at US$28.1 Billion in the year 2022, is projected to reach a revised size of US$38.4 Billion by 2030, growing at aCAGR of 4% over the period 2022-2030. Metabolic Disorders, one of the segments analyzed in the report, is projected to record 5% CAGR and reach US$11.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Immunological Disorders segment is readjusted to a revised 4.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $8.2 Billion, While China is Forecast to Grow at 3.6% CAGR

The Fusion Proteins market in the U.S. is estimated at US$8.2 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.7 Billion by the year 2030 trailing a CAGR of 3.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 2.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Select Competitors (Total 32 Featured)
- Abnova
- Absolute Antibody
- Amgen Science
- Astellas Pharma
- Bristol-Myers Squibb
- Chimerigen
- Genzyme
- Ligand Pharmaceuticals
- NOVUS
- Peprotech
- ProSpec
- Regeneron
- Roche
- Viventia;


Read the full report: https://www.reportlinker.com/p06031657/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Fusion Proteins - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Fusion Proteins by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 2: World Historic Review for Fusion Proteins by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 3: World 16-Year Perspective for Fusion Proteins by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Hematological Disorders by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 5: World Historic Review for Hematological Disorders by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 6: World 16-Year Perspective for Hematological Disorders
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Cancer by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 8: World Historic Review for Cancer by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 9: World 16-Year Perspective for Cancer by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Hormonal Disorders by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 11: World Historic Review for Hormonal Disorders by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 12: World 16-Year Perspective for Hormonal Disorders by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Genetic Disorders by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 14: World Historic Review for Genetic Disorders by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 15: World 16-Year Perspective for Genetic Disorders by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 17: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 18: World 16-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 19: World Fusion Proteins Market Analysis of Annual Sales
in US$ Million for Years 2014 through 2030

Table 20: World Recent Past, Current & Future Analysis for
Metabolic Disorders by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 21: World Historic Review for Metabolic Disorders by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 22: World 16-Year Perspective for Metabolic Disorders by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 23: World Recent Past, Current & Future Analysis for
Immunological Disorders by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 24: World Historic Review for Immunological Disorders by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 25: World 16-Year Perspective for Immunological Disorders
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES
Fusion Proteins Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United States for 2023 (E)
Table 26: USA Recent Past, Current & Future Analysis for Fusion
Proteins by Application - Metabolic Disorders, Immunological
Disorders, Hematological Disorders, Cancer, Hormonal Disorders,
Genetic Disorders and Other Applications - Independent Analysis
of Annual Sales in US$ Million for the Years 2022 through 2030
and % CAGR

Table 27: USA Historic Review for Fusion Proteins by
Application - Metabolic Disorders, Immunological Disorders,
Hematological Disorders, Cancer, Hormonal Disorders, Genetic
Disorders and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 28: USA 16-Year Perspective for Fusion Proteins by
Application - Percentage Breakdown of Value Sales for Metabolic
Disorders, Immunological Disorders, Hematological Disorders,
Cancer, Hormonal Disorders, Genetic Disorders and Other
Applications for the Years 2014, 2023 & 2030

CANADA
Table 29: Canada Recent Past, Current & Future Analysis for
Fusion Proteins by Application - Metabolic Disorders,
Immunological Disorders, Hematological Disorders, Cancer,
Hormonal Disorders, Genetic Disorders and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 30: Canada Historic Review for Fusion Proteins by
Application - Metabolic Disorders, Immunological Disorders,
Hematological Disorders, Cancer, Hormonal Disorders, Genetic
Disorders and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 31: Canada 16-Year Perspective for Fusion Proteins by
Application - Percentage Breakdown of Value Sales for Metabolic
Disorders, Immunological Disorders, Hematological Disorders,
Cancer, Hormonal Disorders, Genetic Disorders and Other
Applications for the Years 2014, 2023 & 2030

JAPAN
Fusion Proteins Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Japan for 2023 (E)
Table 32: Japan Recent Past, Current & Future Analysis for
Fusion Proteins by Application - Metabolic Disorders,
Immunological Disorders, Hematological Disorders, Cancer,
Hormonal Disorders, Genetic Disorders and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 33: Japan Historic Review for Fusion Proteins by
Application - Metabolic Disorders, Immunological Disorders,
Hematological Disorders, Cancer, Hormonal Disorders, Genetic
Disorders and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 34: Japan 16-Year Perspective for Fusion Proteins by
Application - Percentage Breakdown of Value Sales for Metabolic
Disorders, Immunological Disorders, Hematological Disorders,
Cancer, Hormonal Disorders, Genetic Disorders and Other
Applications for the Years 2014, 2023 & 2030

CHINA
Fusion Proteins Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in China for 2023 (E)
Table 35: China Recent Past, Current & Future Analysis for
Fusion Proteins by Application - Metabolic Disorders,
Immunological Disorders, Hematological Disorders, Cancer,
Hormonal Disorders, Genetic Disorders and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 36: China Historic Review for Fusion Proteins by
Application - Metabolic Disorders, Immunological Disorders,
Hematological Disorders, Cancer, Hormonal Disorders, Genetic
Disorders and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 37: China 16-Year Perspective for Fusion Proteins by
Application - Percentage Breakdown of Value Sales for Metabolic
Disorders, Immunological Disorders, Hematological Disorders,
Cancer, Hormonal Disorders, Genetic Disorders and Other
Applications for the Years 2014, 2023 & 2030

EUROPE
Fusion Proteins Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Europe for 2023 (E)
Table 38: Europe Recent Past, Current & Future Analysis for
Fusion Proteins by Geographic Region - France, Germany, Italy,
UK and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2022 through 2030 and % CAGR

Table 39: Europe Historic Review for Fusion Proteins by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 40: Europe 16-Year Perspective for Fusion Proteins by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2014, 2023 & 2030

Table 41: Europe Recent Past, Current & Future Analysis for
Fusion Proteins by Application - Metabolic Disorders,
Immunological Disorders, Hematological Disorders, Cancer,
Hormonal Disorders, Genetic Disorders and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 42: Europe Historic Review for Fusion Proteins by
Application - Metabolic Disorders, Immunological Disorders,
Hematological Disorders, Cancer, Hormonal Disorders, Genetic
Disorders and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 43: Europe 16-Year Perspective for Fusion Proteins by
Application - Percentage Breakdown of Value Sales for Metabolic
Disorders, Immunological Disorders, Hematological Disorders,
Cancer, Hormonal Disorders, Genetic Disorders and Other
Applications for the Years 2014, 2023 & 2030

FRANCE
Fusion Proteins Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in France for 2023 (E)
Table 44: France Recent Past, Current & Future Analysis for
Fusion Proteins by Application - Metabolic Disorders,
Immunological Disorders, Hematological Disorders, Cancer,
Hormonal Disorders, Genetic Disorders and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 45: France Historic Review for Fusion Proteins by
Application - Metabolic Disorders, Immunological Disorders,
Hematological Disorders, Cancer, Hormonal Disorders, Genetic
Disorders and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 46: France 16-Year Perspective for Fusion Proteins by
Application - Percentage Breakdown of Value Sales for Metabolic
Disorders, Immunological Disorders, Hematological Disorders,
Cancer, Hormonal Disorders, Genetic Disorders and Other
Applications for the Years 2014, 2023 & 2030

GERMANY
Fusion Proteins Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Germany for 2023 (E)
Table 47: Germany Recent Past, Current & Future Analysis for
Fusion Proteins by Application - Metabolic Disorders,
Immunological Disorders, Hematological Disorders, Cancer,
Hormonal Disorders, Genetic Disorders and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 48: Germany Historic Review for Fusion Proteins by
Application - Metabolic Disorders, Immunological Disorders,
Hematological Disorders, Cancer, Hormonal Disorders, Genetic
Disorders and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 49: Germany 16-Year Perspective for Fusion Proteins by
Application - Percentage Breakdown of Value Sales for Metabolic
Disorders, Immunological Disorders, Hematological Disorders,
Cancer, Hormonal Disorders, Genetic Disorders and Other
Applications for the Years 2014, 2023 & 2030

ITALY
Table 50: Italy Recent Past, Current & Future Analysis for
Fusion Proteins by Application - Metabolic Disorders,
Immunological Disorders, Hematological Disorders, Cancer,
Hormonal Disorders, Genetic Disorders and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 51: Italy Historic Review for Fusion Proteins by
Application - Metabolic Disorders, Immunological Disorders,
Hematological Disorders, Cancer, Hormonal Disorders, Genetic
Disorders and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 52: Italy 16-Year Perspective for Fusion Proteins by
Application - Percentage Breakdown of Value Sales for Metabolic
Disorders, Immunological Disorders, Hematological Disorders,
Cancer, Hormonal Disorders, Genetic Disorders and Other
Applications for the Years 2014, 2023 & 2030

UNITED KINGDOM
Fusion Proteins Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United Kingdom for 2023 (E)
Table 53: UK Recent Past, Current & Future Analysis for Fusion
Proteins by Application - Metabolic Disorders, Immunological
Disorders, Hematological Disorders, Cancer, Hormonal Disorders,
Genetic Disorders and Other Applications - Independent Analysis
of Annual Sales in US$ Million for the Years 2022 through 2030
and % CAGR

Table 54: UK Historic Review for Fusion Proteins by Application -
Metabolic Disorders, Immunological Disorders, Hematological
Disorders, Cancer, Hormonal Disorders, Genetic Disorders and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 55: UK 16-Year Perspective for Fusion Proteins by
Application - Percentage Breakdown of Value Sales for Metabolic
Disorders, Immunological Disorders, Hematological Disorders,
Cancer, Hormonal Disorders, Genetic Disorders and Other
Applications for the Years 2014, 2023 & 2030

REST OF EUROPE
Table 56: Rest of Europe Recent Past, Current & Future Analysis
for Fusion Proteins by Application - Metabolic Disorders,
Immunological Disorders, Hematological Disorders, Cancer,
Hormonal Disorders, Genetic Disorders and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 57: Rest of Europe Historic Review for Fusion Proteins by
Application - Metabolic Disorders, Immunological Disorders,
Hematological Disorders, Cancer, Hormonal Disorders, Genetic
Disorders and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 58: Rest of Europe 16-Year Perspective for Fusion
Proteins by Application - Percentage Breakdown of Value Sales
for Metabolic Disorders, Immunological Disorders, Hematological
Disorders, Cancer, Hormonal Disorders, Genetic Disorders and
Other Applications for the Years 2014, 2023 & 2030

ASIA-PACIFIC
Fusion Proteins Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Asia-Pacific for 2023 (E)
Table 59: Asia-Pacific Recent Past, Current & Future Analysis
for Fusion Proteins by Application - Metabolic Disorders,
Immunological Disorders, Hematological Disorders, Cancer,
Hormonal Disorders, Genetic Disorders and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 60: Asia-Pacific Historic Review for Fusion Proteins by
Application - Metabolic Disorders, Immunological Disorders,
Hematological Disorders, Cancer, Hormonal Disorders, Genetic
Disorders and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 61: Asia-Pacific 16-Year Perspective for Fusion Proteins
by Application - Percentage Breakdown of Value Sales for
Metabolic Disorders, Immunological Disorders, Hematological
Disorders, Cancer, Hormonal Disorders, Genetic Disorders and
Other Applications for the Years 2014, 2023 & 2030

REST OF WORLD
Table 62: Rest of World Recent Past, Current & Future Analysis
for Fusion Proteins by Application - Metabolic Disorders,
Immunological Disorders, Hematological Disorders, Cancer,
Hormonal Disorders, Genetic Disorders and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 63: Rest of World Historic Review for Fusion Proteins by
Application - Metabolic Disorders, Immunological Disorders,
Hematological Disorders, Cancer, Hormonal Disorders, Genetic
Disorders and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 64: Rest of World 16-Year Perspective for Fusion Proteins
by Application - Percentage Breakdown of Value Sales for
Metabolic Disorders, Immunological Disorders, Hematological
Disorders, Cancer, Hormonal Disorders, Genetic Disorders and
Other Applications for the Years 2014, 2023 & 2030

IV. COMPETITION
Read the full report: https://www.reportlinker.com/p06031657/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

 

            











    

        

        
Contact Data

        


    
    

 
    



        

        
            GlobeNewswire